Related Experiment Video
Updated: Jul 14, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Angiotensin II and oxidative stress
Hirofumi Hitomi1, Hideyasu Kiyomoto, Akira Nishiyama
1Department of Cardiorenal and Cerebrovascular Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan. hitomi@kms.ac.jp
Angiotensin II triggers reactive oxygen species, contributing to cardiovascular disease. While novel mechanisms are revealed, the clinical impact of inhibiting this pathway remains debated.
Area of Science:
- Cardiovascular Physiology
- Oxidative Stress Research
- Molecular Signaling
Background:
- Angiotensin II is a key regulator of vasoconstriction, fluid balance, and cardiac remodeling.
- It activates NAD(P)H oxidase, increasing reactive oxygen species (ROS) production in the cardiovascular system.
- Oxidative stress driven by ROS is implicated in cardiovascular disease progression.
Purpose of the Study:
- To elucidate the mechanisms of ROS formation induced by Angiotensin II.
- To review the pathophysiological effects of Angiotensin II on the cardiovascular system.
- To discuss novel signaling pathways involved in Angiotensin II-mediated ROS production.
Main Methods:
- Review of recent scientific literature on Angiotensin II, ROS, and cardiovascular function.
- Analysis of molecular mechanisms underlying ROS generation by Angiotensin II.
- Examination of signaling pathways including cell proliferation, hypertrophy, and apoptosis.
Main Results:
- Novel molecular mechanisms of Angiotensin II-induced ROS generation and associated signaling pathways have been identified.
- These findings suggest potential benefits of Angiotensin II inhibition for cardiovascular diseases.
- However, the clinical significance of Angiotensin II-induced ROS in cardiovascular outcomes remains controversial.
Conclusions:
- Focus on the impact of Angiotensin II-induced oxidative stress on cardiovascular function and remodeling.
- Discussion of ROS sources and novel signaling pathways in response to Angiotensin II.
- Highlights the ongoing debate regarding the clinical utility of targeting this pathway.
Related Concept Videos
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology

